LAKEESHA BROUGHTON-NELSON: Open Payments
NPI 1134855992 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,604 in 59 payments from 11 companies in 2025. Trend: 2023 $157 · 2024 $1,231 · 2025 $1,604
Food & beverage: $1,604
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $342 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $233 |
| Otsuka America Pharmaceutical, Inc. | 5 | $215 |
| Axsome Therapeutics, Inc. | 4 | $196 |
| Neurocrine BioSciences, Inc. | 9 | $191 |
| ABBVIE INC. | 12 | $141 |
| Lundbeck LLC | 6 | $123 |
| Vanda Pharmaceuticals Inc. | 2 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
Products named: REXULTI, CAPLYTA, ARISTADA, Auvelity, INGREZZA, VRAYLAR, LYBALVI, FANAPT.
Industry payments across AL — which companies pay providers there.
